Zijian Lian, Wei Luo, Jun Liu, Jing Wang, Wei Chai, Yan Wang, Sahil Sethi, Xinlong Ma
{"title":"中国汉族人群中强直性脊柱炎患者的 ANO6、HAPLN1 和 EDIL3 多态性分析:病例对照研究","authors":"Zijian Lian, Wei Luo, Jun Liu, Jing Wang, Wei Chai, Yan Wang, Sahil Sethi, Xinlong Ma","doi":"10.1089/gtmb.2023.0569","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Earlier research has demonstrated a genetic basis for the susceptibility to ankylosing spondylitis (AS) and the severity of AS. By employing a genome-wide association study, recent work has established a correlation between the susceptibility to AS and the <i>ANO6, HAPLN,</i> and <i>EDIL3</i> genes in a Western study population-though alternative studies have not corroborated these findings. This study aims to examine the effects of <i>ANO6</i>, <i>HAPLN1</i>, and <i>EDIL3</i> polymorphisms on the susceptibility and severity of AS among the predominantly Chinese Han population. <b><i>Methods:</i></b> The study involved the collection of blood samples from 497 patients with AS and 498 nonrelated healthy individuals. All participants in the study were human leukocyte antigen (HLA) HLA-B27 positive and of Han Chinese descent. Illness severity was the criteria used for classifying patients with AS. Thirteen tagSNPs in <i>ANO6</i>, <i>HAPLN1</i>, and <i>EDIL3</i> were chosen and then subjected to genetic typing. Analysis was conducted on the occurrence rates of various genotypes and alleles between the control group and patients with varying AS severity. <b><i>Results:</i></b> Following Bonferroni correction, it was found that the rs4768085 and rs17095830 single nucleotide polymorphism (SNPs) in <i>ANO6</i> were related to the susceptibility to AS. Further, the rs6869296 SNP in <i>HAPLN1</i> and the rs2301071 SNP between <i>EDIL3</i> and <i>HAPLN1</i> were also related to AS susceptibility. Regarding AS severity, the rs4768085, rs2897868, rs7965430, and rs11182965 SNPs in <i>ANO6</i> were found to be associated. <b><i>Conclusions:</i></b> Among the Han population in China, the <i>ANO6 and HAPLN1</i> genes are related to the susceptibility to AS; the <i>ANO6</i> gene is also associated with the severity of AS.</p>","PeriodicalId":12603,"journal":{"name":"Genetic testing and molecular biomarkers","volume":" ","pages":"385-392"},"PeriodicalIF":1.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of <i>ANO6, HAPLN1</i>, and <i>EDIL3</i> Polymorphisms in Patients with Ankylosing Spondylitis in a Chinese Han Population: A Case-Control Study.\",\"authors\":\"Zijian Lian, Wei Luo, Jun Liu, Jing Wang, Wei Chai, Yan Wang, Sahil Sethi, Xinlong Ma\",\"doi\":\"10.1089/gtmb.2023.0569\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Earlier research has demonstrated a genetic basis for the susceptibility to ankylosing spondylitis (AS) and the severity of AS. By employing a genome-wide association study, recent work has established a correlation between the susceptibility to AS and the <i>ANO6, HAPLN,</i> and <i>EDIL3</i> genes in a Western study population-though alternative studies have not corroborated these findings. This study aims to examine the effects of <i>ANO6</i>, <i>HAPLN1</i>, and <i>EDIL3</i> polymorphisms on the susceptibility and severity of AS among the predominantly Chinese Han population. <b><i>Methods:</i></b> The study involved the collection of blood samples from 497 patients with AS and 498 nonrelated healthy individuals. All participants in the study were human leukocyte antigen (HLA) HLA-B27 positive and of Han Chinese descent. Illness severity was the criteria used for classifying patients with AS. Thirteen tagSNPs in <i>ANO6</i>, <i>HAPLN1</i>, and <i>EDIL3</i> were chosen and then subjected to genetic typing. Analysis was conducted on the occurrence rates of various genotypes and alleles between the control group and patients with varying AS severity. <b><i>Results:</i></b> Following Bonferroni correction, it was found that the rs4768085 and rs17095830 single nucleotide polymorphism (SNPs) in <i>ANO6</i> were related to the susceptibility to AS. Further, the rs6869296 SNP in <i>HAPLN1</i> and the rs2301071 SNP between <i>EDIL3</i> and <i>HAPLN1</i> were also related to AS susceptibility. Regarding AS severity, the rs4768085, rs2897868, rs7965430, and rs11182965 SNPs in <i>ANO6</i> were found to be associated. <b><i>Conclusions:</i></b> Among the Han population in China, the <i>ANO6 and HAPLN1</i> genes are related to the susceptibility to AS; the <i>ANO6</i> gene is also associated with the severity of AS.</p>\",\"PeriodicalId\":12603,\"journal\":{\"name\":\"Genetic testing and molecular biomarkers\",\"volume\":\" \",\"pages\":\"385-392\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genetic testing and molecular biomarkers\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/gtmb.2023.0569\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic testing and molecular biomarkers","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/gtmb.2023.0569","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Analysis of ANO6, HAPLN1, and EDIL3 Polymorphisms in Patients with Ankylosing Spondylitis in a Chinese Han Population: A Case-Control Study.
Background: Earlier research has demonstrated a genetic basis for the susceptibility to ankylosing spondylitis (AS) and the severity of AS. By employing a genome-wide association study, recent work has established a correlation between the susceptibility to AS and the ANO6, HAPLN, and EDIL3 genes in a Western study population-though alternative studies have not corroborated these findings. This study aims to examine the effects of ANO6, HAPLN1, and EDIL3 polymorphisms on the susceptibility and severity of AS among the predominantly Chinese Han population. Methods: The study involved the collection of blood samples from 497 patients with AS and 498 nonrelated healthy individuals. All participants in the study were human leukocyte antigen (HLA) HLA-B27 positive and of Han Chinese descent. Illness severity was the criteria used for classifying patients with AS. Thirteen tagSNPs in ANO6, HAPLN1, and EDIL3 were chosen and then subjected to genetic typing. Analysis was conducted on the occurrence rates of various genotypes and alleles between the control group and patients with varying AS severity. Results: Following Bonferroni correction, it was found that the rs4768085 and rs17095830 single nucleotide polymorphism (SNPs) in ANO6 were related to the susceptibility to AS. Further, the rs6869296 SNP in HAPLN1 and the rs2301071 SNP between EDIL3 and HAPLN1 were also related to AS susceptibility. Regarding AS severity, the rs4768085, rs2897868, rs7965430, and rs11182965 SNPs in ANO6 were found to be associated. Conclusions: Among the Han population in China, the ANO6 and HAPLN1 genes are related to the susceptibility to AS; the ANO6 gene is also associated with the severity of AS.
期刊介绍:
Genetic Testing and Molecular Biomarkers is the leading peer-reviewed journal covering all aspects of human genetic testing including molecular biomarkers. The Journal provides a forum for the development of new technology; the application of testing to decision making in an increasingly varied set of clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling. This is the definitive resource for researchers, clinicians, and scientists who develop, perform, and interpret genetic tests and their results.
Genetic Testing and Molecular Biomarkers coverage includes:
-Diagnosis across the life span-
Risk assessment-
Carrier detection in individuals, couples, and populations-
Novel methods and new instrumentation for genetic testing-
Results of molecular, biochemical, and cytogenetic testing-
Genetic counseling